|
|
Article: Allergan Reports Third Quarter Operating Results; Pharmaceutical Sales Increased 15 Percent for the Third Quarter; Board of Directors Declares Third Quarter Dividend.
- Article from:
- Business Wire
- Article date:
- November 1, 2004
CopyrightCOPYRIGHT 2004 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
IRVINE, Calif. -- Allergan, Inc. (NYSE:AGN) today announced operating results for the third quarter ended September 24, 2004. Allergan also announced that its Board of Directors has declared a third quarter dividend of $0.09 per share, payable on December 9, 2004, to stockholders of record on November 10, 2004.
Operating Results
For the quarter ended September 24, 2004:
--Allergan's net sales were $510.8 million, including $26.0 million of non-pharmaceutical product sales, primarily consisting of contract manufacturing sales to Advanced Medical Optics, Inc. (AMO), a former subsidiary that was spun-off from Allergan on June 29, 2002.
...
Related newspaper, magazine, and journal articles:
|
|
Article: Allergan Reports First Quarter Operating Results.
Business Wire;
April 30, 2004 ;
700+ words
... ... first quarter of 2004: -- Allergan announced that Apotex, Inc., Apotex ... entered into an agreement with Allergan to promote Zymar(TM) in the ... pediatric specialty market. -- Allergan announced that it was selected as a partner ...
|
|